Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

With the routine use of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, the number of life-threatening coronavirus disease 2019 (COVID-19) courses have largely been reduced. However, multiple COVID-19 convalescents, even after asymptomatic to moderate disease, suffer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackenbruch, Christopher, Maringer, Yacine, Tegeler, Christian M., Walz, Juliane S., Nelde, Annika, Heitmann, Jonas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051370/
https://www.ncbi.nlm.nih.gov/pubmed/36992410
http://dx.doi.org/10.3390/v15030701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051370/
https://www.ncbi.nlm.nih.gov/pubmed/36992410
http://dx.doi.org/10.3390/v15030701

Ejemplares similares